This is not the latest version of this item. The latest version can be found here.
Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model
Name
1956.full.pdf
Description
Published version
Size
6.72 MB
Format
Adobe PDF
Checksum (MD5)
739467be46a963ee33edd08ac70eddaa
Author(s) • • • • • • • • •
Meilandt, William J
Ngu, Hai
Gogineni, Alvin
Lalehzadeh, Guita
Lee, Seung-Hye
Srinivasan, Karpagam
Imperio, Jose
Wu, Tiffany
Weber, Martin
Kruse, Agatha J
Date Issued
2020
Journal
Journal of Neuroscience
Publisher
Society for Neuroscience
Version
Final published version
Abstract
Copyright © 2020 Meilandt et al. TREM2 is an Alzheimer’s disease (AD) risk gene expressed in microglia. To study the role of Trem2 in a mouse model of β-amyloidosis, we compared PS2APP transgenic mice versus PS2APP mice lacking Trem2 (PS2APP;Trem2 ko) at ages ranging from 4 to 22 months. Microgliosis was impaired in PS2APP;Trem2 ko mice, with Trem2-deficient microglia showing compromised expression of proliferation/ Wnt-related genes and marked accumulation of ApoE. Plaque abundance was elevated in PS2APP;Trem2 ko females at 6 –7 months; but by 12 or 19 –22 months of age, it was notably diminished in female and male PS2APP;Trem2 ko mice, respectively. Across all ages, plaque morphology was more diffuse in PS2APP;Trem2 ko brains, and the Aβ42:Aβ40 ratio was elevated. The amount of soluble, fibrillar Aβ oligomers also increased in PS2APP;Trem2 ko hippocampi. Associated with these changes, axonal dystrophy was exacerbated from 6 to 7 months onward in PS2APP;Trem2 ko mice, notwithstanding the reduced plaque load at later ages. PS2APP;Trem2 ko mice also exhibited more dendritic spine loss around plaque and more neurofilament light chain in CSF. Thus, aggravated neuritic dystrophy is a more consistent outcome of Trem2 deficiency than amyloid plaque load, suggesting that the microglial packing of Aβ into dense plaque is an important neuroprotective activity.
Terms of Use
Creative Commons Attribution 4.0 International license
Persistent DSpace Link
DOI of Published Version
10.1523/JNEUROSCI.1871-19.2019